What is the current market size?

The In Vitro Diagnosis (IVD) Consumables market size reached USD 1.2 billion in 2023, driven by rising demand for rapid diagnostics and chronic disease prevalence.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by advancements in molecular diagnostics and personalized medicine.

What are the key growth drivers?

Key drivers include aging populations, increasing infectious disease outbreaks, and technological innovations in automated testing platforms.

What challenges hinder market growth?

High R&D costs, stringent regulatory compliance, and supply chain disruptions pose significant challenges to market expansion.

Which regions lead the market?

North America dominates due to advanced healthcare infrastructure, while Asia-Pacific shows high growth potential from emerging economies.

Who are the top companies?

Leading players include Thermo Fisher Scientific, Roche Diagnostics, and Abbott Laboratories, focusing on product diversification and strategic partnerships.

What opportunities lie ahead?

Opportunities exist in point-of-care testing (POCT) adoption, expanding applications in oncology, and AI-integrated diagnostic solutions.

How does technology impact the market?

Advancements in next-generation sequencing (NGS) and lab-on-a-chip technologies enhance accuracy and efficiency, driving market evolution.

What is the regulatory landscape?

Regulations like the EU’s In Vitro Diagnostic Regulation (IVDR) and FDA guidelines ensure safety but require compliance investments from manufacturers.

Why Is the In Vitro Diagnosis (IVD) Consumables Market Growing So Fast? 2026 Analysis

In Vitro Diagnosis (IVD) Consumables by Application (Physical Examination, Chronic Disease Management, Heavy Disease Surveillance), by Types (Reagents, Sample Vials, Test Tubes, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $75000 million

CAGR: 8.7%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $75000 million

CAGR: 8.7%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

In Vitro Diagnosis (IVD) Consumables Market Overview

The In Vitro Diagnosis (IVD) Consumables market encompasses disposable and single-use products critical for diagnostic testing, including reagents, test kits, and sample collection tools. These consumables are foundational to clinical decision-making, enabling applications in infectious disease detection, chronic condition monitoring, and personalized medicine. The IVD consumables market size reached $28.6 billion in 2026, reflecting steady industry expansion driven by rising diagnostic demand and technological innovation.

Loading chart…

The IVD consumables market forecast projects a 7.2% CAGR from 2026 to 2033, with reagents dominating revenue shares due to their integral role in advanced testing workflows. Key drivers include the proliferation of point-of-care diagnostics and regulatory support for rapid testing in emerging markets. Technological shifts toward automation and AI-driven analytics are reshaping supply chains, while Asia-Pacific emerges as the fastest-growing region, fueled by urbanization and expanding healthcare infrastructure. North America remains the largest market, underpinned by robust R&D ecosystems and adoption of next-generation sequencing.

Report Overview

Report Attribute	Details
Market size value in 2025	75.00 billion
Revenue forecast in 2033	146.18 billion
Growth rate	CAGR of 8.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Becton; COMING Medical; Danaher Corporation; Johnson and Johnson; Qiagen; Roche; Siemens; Sysmex; Thermo Fisher Scientific Inc.; Weidmann Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The In Vitro Diagnosis (IVD) Consumables market is propelled by the rising prevalence of chronic diseases and infectious diseases, driving demand for accurate and rapid diagnostic testing. Advanced technologies such as molecular diagnostics and next-generation sequencing are enhancing test sensitivity, further expanding market adoption.

Personalized medicine and precision healthcare initiatives are accelerating the need for customized IVD consumables. Companion diagnostics, which require specialized reagents and assays, are gaining traction in oncology and rare disease management, directly influencing the IVD Consumables market size.

Restraints2 items

High costs associated with R&D and regulatory approvals for novel IVD consumables act as a barrier, particularly in emerging markets. Stringent compliance requirements under standards like ISO 13485 and CLIA add to operational complexities and delays in market entry.

Price competition from generic diagnostic kits and the shift toward cost containment by healthcare payers are compressing profit margins. Budget-conscious healthcare systems in low-income regions prioritize affordability over cutting-edge solutions, limiting market expansion.

Opportunities2 items

The growing adoption of point-of-care (POCT) diagnostics in decentralized healthcare settings presents untapped potential. Miniaturized IVD consumables for rapid antigen testing and handheld analyzers are expected to gain prominence, aligning with the growth forecast for the IVD Consumables market.

Digital health integration, including AI-driven diagnostic platforms and connected devices, is creating demand for compatible IVD consumables. Partnerships between IVD manufacturers and digital health startups could unlock new revenue streams and improve diagnostic workflows.

Challenges2 items

Fragmented regulatory environments across regions create compliance hurdles, delaying product launches and increasing operational costs. Divergent approval timelines in the EU, U.S., and Asia-Pacific regions complicate global market strategies.

Supply chain vulnerabilities, such as raw material shortages and geopolitical tensions, threaten the stability of IVD consumables production. This is exacerbated by the reliance on single-source suppliers for critical components like monoclonal antibodies and polymer microspheres.

Market Segmentation

Loading chart…

The In Vitro Diagnosis (IVD) Consumables market is segmented by Application, with Clinical Diagnostics and Research as primary subcategories. Clinical Diagnostics dominates, driven by hospital and lab testing for disease detection, contributing ~65% of revenue. Research applications, including academic and biotech studies, account for ~35%, fueled by R&D for diagnostic innovation. This market taxonomy highlights the sector’s reliance on healthcare infrastructure and scientific advancement, with clinical testing ensuring immediate revenue while research catalyzes long-term growth.

Types segmentation includes Reagents and Consumables. Reagents (e.g., enzymes, antibodies) constitute ~55% of the market, critical for biochemical assays and immunoassays. Their demand is tied to assay complexity and test frequency. Consumables (e.g., microplates, pipette tips) account for ~45%, driven by high-volume usage in labs. This division underscores the market’s dependence on recurring purchases, with reagents enabling diagnostic accuracy and consumables ensuring operational continuity.

In Vitro Diagnosis (IVD) Consumables Segmentation Breakdown9 items

Application

Physical Examination

Chronic Disease Management

Heavy Disease Surveillance

Types

Reagents

Sample Vials

Test Tubes

Others

Regional Insights

Loading chart…

The In Vitro Diagnosis (IVD) Consumables market growth is led by North America, accounting for 38% of global share, driven by advanced healthcare infrastructure, high R&D investment, and stringent regulatory frameworks fostering innovation. The Asia Pacific region emerges as the fastest-growing market, with a projected CAGR exceeding 9.5%, fueled by rising chronic disease prevalence, expanding healthcare access, and government initiatives like India’s Production Linked Incentive (PLI) scheme.

Europe holds 28% of the market, supported by robust healthcare policies, aging demographics, and ecosystem maturity in digital diagnostics. Latin America (10%) and the Middle East & Africa (4%) are gaining traction through improved healthcare access, partnerships with global players, and rising demand for cost-effective diagnostic solutions in underserved regions.

Key drivers across regions include: technological adoption, demographic shifts, and policy reforms. North America benefits from AI integration in diagnostics; Europe prioritizes quality standards under the EU MDR; Asia Pacific leverages demographic growth and infrastructure expansion. Latin America and Middle East & Africa see momentum from public-private investments and mobile diagnostic units.

Competitive Landscape

The In Vitro Diagnosis (IVD) Consumables market is moderately consolidated, with a mix of global leaders and regional players vying for market share. Competitors leverage differentiated strategies, including pricing flexibility, regulatory compliance, and product portfolio breadth. Key players prioritize innovation in diagnostic accuracy, rapid regulatory approvals (e.g., CE marking, FDA clearance), and partnerships with OEMs to secure long-term contracts. Fragmentation persists in niche segments such as point-of-care testing, where local suppliers capitalize on localized distribution networks. The In Vitro Diagnosis (IVD) Consumables competitive landscape is shaped by intense competition in high-growth markets, driven by demand for cost-effective solutions and advancements in multiplex testing technologies.

Strategic initiatives include M&A to consolidate R&D capabilities, joint ventures for geographic expansion, and localized manufacturing to mitigate supply chain risks. Competitive differentiation centers on proprietary technologies (e.g., isothermal amplification, microfluidics), service-level agreements, and customization for hospital-specific workflows. A critical challenge is margin compression due to commoditization in core consumables like reagents and assay kits. Companies are also navigating rising compliance costs from evolving CLIA and ISO standards, which widen barriers to entry for smaller players.

Thermo Fisher Scientific Inc.: innovation pipeline in next-gen sequencing reagents

Roche: technology integration with automation platforms for diagnostic workflows

Abbott: regional expansion via local manufacturing in Asia-Pacific emerging markets

Danaher Corporation: vertical integration to optimize consumables production costs

Siemens Healthineers: OEM tie-ups for bundled diagnostic system-consumable sales

Qiagen: premium pricing for molecular diagnostic consumables with rapid result delivery

Key In Vitro Diagnosis (IVD) Consumables Companies11 items

Abbott

Becton

COMING Medical

Danaher Corporation

Johnson and Johnson

Qiagen

Roche

Siemens

Sysmex

Thermo Fisher Scientific Inc.

Weidmann Medical

Market Ecosystem

The In Vitro Diagnosis (IVD) Consumables ecosystem spans raw material sourcing to end-user application. Upstream participants supply critical components and technologies, midstream manufacturers assemble diagnostic consumables, and downstream entities distribute and deploy products. Value is generated through innovation in diagnostic accuracy, supply chain efficiency, and regulatory compliance across healthcare settings.

Raw material/component suppliers — provide reagents, plastics, and specialty chemicals for consumable production

OEMs / manufacturers — design and produce IVD consumables including test kits and assay components

Technology providers — develop diagnostic platforms and software enabling consumable integration

Distributors / channel partners — facilitate regional product access via direct sales or third-party networks

Service providers / after-sales — offer calibration, maintenance, and technical support for diagnostic systems

End users / buyers — hospitals, labs, and point-of-care facilities utilizing IVD consumables

Regulators/standards bodies — enforce quality controls and certification requirements for market entry

Control points reside with regulators, who dictate approval timelines, and raw material suppliers, whose availability impacts production. End users face switching costs tied to equipment compatibility and validated workflows. Strategic partnerships between manufacturers and distributors ensure supply chain resilience, while interoperability standards govern integration between diagnostic platforms and consumables.

Recent Industry Insights

The In Vitro Diagnosis (IVD) Consumables industry trends have evolved rapidly over the past 18 months, driven by technological innovation and global healthcare demands. Strategic partnerships have surged, with key players like Roche and Abbott forming alliances to enhance diagnostic capabilities in point-of-care (POC) testing. Mergers & acquisitions have intensified, exemplified by Thermo Fisher Scientific’s acquisition of a molecular diagnostics firm in 2023, strengthening its IVD portfolio. Product/technology launches highlight advancements in automated immunoassay systems, such as the QIAGEN GeneRead NGS panel for precision oncology, and AI-integrated platforms like Siemens Healthineers’ Atellica Solution for streamlined workflows. Regulatory shifts, notably the EU’s In Vitro Diagnostic Regulation (IVDR) implementation in May 2024, have reshaped compliance standards, pushing manufacturers to prioritize traceability and risk management. Consumer and enterprise trends show growing demand for decentralized testing, with POC diagnostics adoption rising by 22% in hospitals. Funding rounds have surged for startups specializing in rapid antigen detection and CRISPR-based assays, with over $1.2 billion raised in 2023 alone, reflecting investor confidence in scalable diagnostic solutions.

Analyst Overview

The In Vitro Diagnosis (IVD) Consumables market outlook remains robust, driven by rising demand for precision medicine, an aging global population, and the proliferation of chronic diseases. Market attractiveness is amplified by its critical role in diagnostic workflows, spanning infectious disease screening, cancer biomarkers, and point-of-care testing. Competitive intensity is high, with established players focusing on R&D partnerships and emerging firms targeting niche applications. However, differentiation opportunities persist in regions with underdeveloped healthcare infrastructure.

The long-term outlook is optimistic, supported by advancements in multiplex testing, AI-enabled analytics, and decentralized diagnostic models. Innovation is concentrated in sustainable product design and automation-compatible consumables. Despite strong demand, supply constraints linked to raw material volatility and geopolitical trade shifts could pose near-term risks. Strategic players must also navigate regulatory complexity and reimbursement challenges, which remain key threats to margin stability.

Key Risk Factors4 items

Regulatory divergences across markets

Economic downturns impacting healthcare budgets

Supply chain disruptions for critical reagents

Technological commoditization pressures

11 items

1. Executive Summary

2. In Vitro Diagnosis (IVD) Consumables Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global In Vitro Diagnosis (IVD) Consumables Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global In Vitro Diagnosis (IVD) Consumables Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Physical Examination

6.1.2. Chronic Disease Management

6.1.3. Heavy Disease Surveillance

6.2. Global In Vitro Diagnosis (IVD) Consumables Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Reagents

6.2.2. Sample Vials

6.2.3. Test Tubes

6.2.4. Others

6.3. Global In Vitro Diagnosis (IVD) Consumables Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global In Vitro Diagnosis (IVD) Consumables Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global In Vitro Diagnosis (IVD) Consumables Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global In Vitro Diagnosis (IVD) Consumables Market Competition by Key Manufacturers

8.1. Global In Vitro Diagnosis (IVD) Consumables Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global In Vitro Diagnosis (IVD) Consumables: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Becton

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. COMING Medical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Danaher Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Johnson and Johnson

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Qiagen

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Roche

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Siemens

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Sysmex

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Thermo Fisher Scientific Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Weidmann Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global In Vitro Diagnosis (IVD) Consumables Market

Figure 4: Global In Vitro Diagnosis (IVD) Consumables Market: Drivers

Figure 5: Global In Vitro Diagnosis (IVD) Consumables Market: Challenges

Figure 6: Global In Vitro Diagnosis (IVD) Consumables Market: Trends

Figure 7: Global In Vitro Diagnosis (IVD) Consumables Market: Opportunity

Figure 8: Global In Vitro Diagnosis (IVD) Consumables Market: Restraint

Figure 9: Global In Vitro Diagnosis (IVD) Consumables Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global In Vitro Diagnosis (IVD) Consumables Market Value (USD Million) By Region

Figure 15: Global In Vitro Diagnosis (IVD) Consumables Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global In Vitro Diagnosis (IVD) Consumables Market Value (USD Million) By Region

Figure 23: Global In Vitro Diagnosis (IVD) Consumables Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global In Vitro Diagnosis (IVD) Consumables Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global In Vitro Diagnosis (IVD) Consumables Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global In Vitro Diagnosis (IVD) Consumables Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global In Vitro Diagnosis (IVD) Consumables Market Value (USD Million) By Region

Table 10: Global In Vitro Diagnosis (IVD) Consumables Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global In Vitro Diagnosis (IVD) Consumables Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global In Vitro Diagnosis (IVD) Consumables Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global In Vitro Diagnosis (IVD) Consumables Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: Becton Basic Information And Sales Area

Table 33: Becton. Products Portfolio

Table 34: COMING Medical Basic Information And Sales Area

Table 35: COMING Medical. Products Portfolio

Table 36: Danaher Corporation Basic Information And Sales Area

Table 37: Danaher Corporation. Products Portfolio

Table 38: Johnson and Johnson Basic Information And Sales Area

Table 39: Johnson and Johnson. Products Portfolio

Table 40: Qiagen Basic Information And Sales Area

Table 41: Qiagen. Products Portfolio

Table 42: Roche Basic Information And Sales Area

Table 43: Roche. Products Portfolio

Table 44: Siemens Basic Information And Sales Area

Table 45: Siemens. Products Portfolio

Table 46: Sysmex Basic Information And Sales Area

Table 47: Sysmex. Products Portfolio

Table 48: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 49: Thermo Fisher Scientific Inc.. Products Portfolio

Table 50: Weidmann Medical Basic Information And Sales Area

Table 51: Weidmann Medical. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global In Vitro Diagnosis (IVD) Consumables Market Value (USD Million) By Region

Table 57: Global In Vitro Diagnosis (IVD) Consumables Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

In Vitro Diagnosis (IVD) Consumables Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	75.00 billion
Revenue forecast in 2033	146.18 billion
Growth rate	CAGR of 8.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Becton; COMING Medical; Danaher Corporation; Johnson and Johnson; Qiagen; Roche; Siemens; Sysmex; Thermo Fisher Scientific Inc.; Weidmann Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

In Vitro Diagnosis (IVD) Consumables Segmentation Breakdown9 items

Application

Physical Examination

Chronic Disease Management

Heavy Disease Surveillance

Types

Reagents

Sample Vials

Test Tubes

Others

Regional Insights

Loading chart…

Competitive Landscape

Thermo Fisher Scientific Inc.: innovation pipeline in next-gen sequencing reagents

Roche: technology integration with automation platforms for diagnostic workflows

Abbott: regional expansion via local manufacturing in Asia-Pacific emerging markets

Danaher Corporation: vertical integration to optimize consumables production costs

Siemens Healthineers: OEM tie-ups for bundled diagnostic system-consumable sales

Qiagen: premium pricing for molecular diagnostic consumables with rapid result delivery

Key In Vitro Diagnosis (IVD) Consumables Companies11 items

Abbott

Becton

COMING Medical

Danaher Corporation

Johnson and Johnson

Qiagen

Roche

Siemens

Sysmex

Thermo Fisher Scientific Inc.

Weidmann Medical

Market Ecosystem

Raw material/component suppliers — provide reagents, plastics, and specialty chemicals for consumable production

OEMs / manufacturers — design and produce IVD consumables including test kits and assay components

Technology providers — develop diagnostic platforms and software enabling consumable integration

Distributors / channel partners — facilitate regional product access via direct sales or third-party networks

Service providers / after-sales — offer calibration, maintenance, and technical support for diagnostic systems

End users / buyers — hospitals, labs, and point-of-care facilities utilizing IVD consumables

Regulators/standards bodies — enforce quality controls and certification requirements for market entry

Recent Industry Insights

Analyst Overview

Key Risk Factors4 items

Regulatory divergences across markets

Economic downturns impacting healthcare budgets

Supply chain disruptions for critical reagents

Technological commoditization pressures

Table of Contents